Skip to main content
Log in

Speed Switch in Glioblastoma Growth Rate due to Enhanced Hypoxia-Induced Migration

  • Original Article
  • Published:
Bulletin of Mathematical Biology Aims and scope Submit manuscript

Abstract

We analyze the wave speed of the Proliferation Invasion Hypoxia Necrosis Angiogenesis (PIHNA) model that was previously created and applied to simulate the growth and spread of glioblastoma (GBM), a particularly aggressive primary brain tumor. We extend the PIHNA model by allowing for different hypoxic and normoxic cell migration rates and study the impact of these differences on the wave-speed dynamics. Through this analysis, we find key variables that drive the outward growth of the simulated GBM. We find a minimum tumor wave-speed for the model; this depends on the migration and proliferation rates of the normoxic cells and is achieved under certain conditions on the migration rates of the normoxic and hypoxic cells. If the hypoxic cell migration rate is greater than the normoxic cell migration rate above a threshold, the wave speed increases above the predicted minimum. This increase in wave speed is explored through an eigenvalue and eigenvector analysis of the linearized PIHNA model, which yields an expression for this threshold. The PIHNA model suggests that an inherently faster-diffusing hypoxic cell population can drive the outward growth of a GBM as a whole, and that this effect is more prominent for faster-proliferating tumors that recover relatively slowly from a hypoxic phenotype. The findings presented here act as a first step in enabling patient-specific calibration of the PIHNA model.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  • Adair JE, Johnston SK, Mrugala MM, Beard BC, Guyman LA, Baldock AL, Bridge CA, Hawkins-Daarud A, Gori JL, Born DE et al (2014) Gene therapy enhances chemotherapy tolerance and efficacy in glioblastoma patients. J Clin Investig 124(9):4082–4092

    Article  Google Scholar 

  • Baldock AL, Sunyoung A, Russell R, Johnston SK, Neal M, David C, Kamala C-S, Greg S, Trister AD, Malone H et al (2014a) Patient-specific metrics of invasiveness reveal significant prognostic benefit of resection in a predictable subset of gliomas. PLoS ONE 9(10):e99057

    Article  Google Scholar 

  • Baldock AL, Yagle K, Born DE, Ahn S, Trister AD, Neal M, Johnston SK, Bridge CA, Basanta D, Scott J et al (2014b) Invasion and proliferation kinetics in enhancing gliomas predict IDH1 mutation status. Neuro-oncology 16(6):779–786

    Article  Google Scholar 

  • Bell C, Dowson N, Fay M, Thomas P, Puttick S, Gal Y, Rose S (2015) Hypoxia imaging in gliomas with 18f-fluoromisonidazole pet: toward clinical translation. In: Seminars in nuclear medicine, vol 45. Elsevier, pp 136–150

  • Brat DJ, Castellano-Sanchez AA, Hunter SB, Pecot M, Cohen C, Hammond EH, Devi SN, Kaur B, Van Meir EG (2004) Pseudopalisades in glioblastoma are hypoxic, express extracellular matrix proteases, and are formed by an actively migrating cell population. Cancer Res 64(3):920–927

    Article  Google Scholar 

  • Fisher RA (1937) The wave of advance of advantageous genes. Ann Eugen 7(4):355–369

    Article  MATH  Google Scholar 

  • Giese A, Bjerkvig R, Berens ME, Westphal M (2003) Cost of migration: invasion of malignant gliomas and implications for treatment. J Clin Oncol 21(8):1624–1636

    Article  Google Scholar 

  • Gordan JD, Simon MC (2007) Hypoxia-inducible factors: central regulators of the tumor phenotype. Curr Opin Genet Dev 17(1):71–77

    Article  Google Scholar 

  • Harpold HLP, Alvord EC, Swanson KR (2007) The evolution of mathematical modeling of glioma proliferation and invasion. J Neuropathol Exp Neurol 66(1):1–9

    Article  Google Scholar 

  • Hawkins-Daarud A, Rockne RC, Anderson ARA, Swanson KR (2013) Modeling tumor-associated edema in gliomas during anti-angiogenic therapy and its impact on imageable tumor. Front Oncol 3:66

    Article  Google Scholar 

  • Hawkins-Daarud A, Rockne R, Corwin D, Anderson ARA, Kinahan P, Swanson KR (2015) In silico analysis suggests differential response to bevacizumab and radiation combination therapy in newly diagnosed glioblastoma. J R Soc Interface 12(109):20150388

    Article  Google Scholar 

  • Keunen O, Johansson M, Oudin A, Sanzey M, Rahim SAA, Fack F, Thorsen F, Taxt T, Bartos M, Jirik R et al (2011) Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma. Proc Natl Acad Sci 108(9):3749–3754

    Article  Google Scholar 

  • Korkolopoulou P, Patsouris E, Konstantinidou AE, Pavlopoulos PM, Kavantzas N, Boviatsis E, Thymara I, Perdiki M, Thomas-Tsagli E, Angelidakis D et al (2004) Hypoxia-inducible factor 1\(\alpha \)/vascular endothelial growth factor axis in astrocytomas. associations with microvessel morphometry, proliferation and prognosis. Neuropathol Appl Neurobiol 30(3):267–278

    Article  Google Scholar 

  • Louis D, Ohgaki H, Wiestler O, Cavenee W (2016) WHO classification of tumours of the central nervous system, 4th edn. International Agency for Research on Cancer, Lyon

    Google Scholar 

  • Martínez-González A, Calvo GF, Romasanta LAP, Pérez-García VM (2012) Hypoxic cell waves around necrotic cores in glioblastoma: a biomathematical model and its therapeutic implications. Bull Math Biol 74(12):2875–2896

    Article  MathSciNet  MATH  Google Scholar 

  • Massey SC, Assanah MC, Lopez KA, Canoll P, Swanson KR (2012) Glial progenitor cell recruitment drives aggressive glioma growth: mathematical and experimental modelling. J R Soc Interface 9(73):1757–1766

    Article  Google Scholar 

  • Neal ML, Trister AD, Cloke T, Sodt R, Ahn S, Baldock AL, Bridge CA, Lai A, Cloughesy TF, Mrugala MM et al (2013a) Discriminating survival outcomes in patients with glioblastoma using a simulation-based, patient-specific response metric. PloS ONE 8(1):e51951

    Article  Google Scholar 

  • Neal ML, Trister AD, Ahn S, Baldock A, Bridge CA, Guyman L, Lange J, Sodt R, Cloke T, Lai A et al (2013b) Response classification based on a minimal model of glioblastoma growth is prognostic for clinical outcomes and distinguishes progression from pseudoprogression. Cancer Res 73(10):2976–2986

    Article  Google Scholar 

  • Raza SM, Lang FF, Aggarwal BB, Fuller GN, Wildrick DM, Sawaya R (2002) Necrosis and glioblastoma: a friend or a foe? A review and a hypothesis. Neurosurgery 51(1):2–13

    Article  Google Scholar 

  • Roniotis A, Sakkalis V, Tzamali E, Tzedakis G, Zervakis M, Marias K (2012) Solving the pihna model while accounting for radiotherapy. In: Advanced research workshop on in silico oncology and cancer investigation—The TUMOR project workshop (IARWISOCI), 2012 5th International. IEEE, pp 1–4

  • Silbergeld DL, Chicoine MR (1997) Isolation and characterization of human malignant glioma cells from histologically normal brain. J Neurosurg 86(3):525–531

    Article  Google Scholar 

  • Singleton KW, Porter AB, Hu LS, Johnston SK, Bond KM, Rickertsen CR, De Leon G, Whitmire SA, Clark-Swanson KR, Mrugala MM et al (2019) Days gained response discriminates treatment response in patients with recurrent glioblastoma receiving bevacizumab-based therapies. bioRxiv, p 752402

  • Spence AM, Muzi M, Swanson KR, O’Sullivan F, Rockhill JK, Rajendran JG, Adamsen TCH, Link JM, Swanson PE, Yagle KJ et al (2008) Regional hypoxia in glioblastoma multiforme quantified with [18f] fluoromisonidazole positron emission tomography before radiotherapy: correlation with time to progression and survival. Clin Cancer Res 14(9):2623–2630

    Article  Google Scholar 

  • Stupp R, Mason WP, Van Den Bent MJ, Weller M, Fisher B, Taphoorn MJB, Belanger K, Brandes AA, Marosi C, Bogdahn U et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987–996

    Article  Google Scholar 

  • Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJB, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K et al (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the eortc-ncic trial. Lancet Oncol 10(5):459–466

    Article  Google Scholar 

  • Swan A, Hillen T, Bowman JC, Murtha AD (2018) A patient-specific anisotropic diffusion model for brain tumour spread. Bull Math Biol 80(5):1259–1291

    Article  MathSciNet  MATH  Google Scholar 

  • Swanson KR (1999) Mathematical modeling of the growth and control of tumors. University of Washington, Seattle, WA

    Google Scholar 

  • Swanson KR, Alvord EC Jr, Murray JD (2000) A quantitative model for differential motility of gliomas in grey and white matter. Cell Prolif 33(5):317–29

    Article  Google Scholar 

  • Swanson KR, Bridge C, Murray JD, Alvord EC (2003a) Virtual and real brain tumors: using mathematical modeling to quantify glioma growth and invasion. J Neurol Sci 216(1):1–10

    Article  Google Scholar 

  • Swanson KR, Bridge C, Murray JD, Alvord EC Jr (2003b) Virtual and real brain tumors: using mathematical modeling to quantify glioma growth and invasion. J Neurol Sci 216(1):1–10

    Article  Google Scholar 

  • Swanson KR, Rostomily RC, Alvord EC Jr (2008) A mathematical modelling tool for predicting survival of individual patients following resection of glioblastoma: a proof of principle. Br J Cancer 98(1):113–119

    Article  Google Scholar 

  • Swanson KR, Rockne RC, Claridge J, Chaplain MAJ, Alvord EC, Anderson ARA (2011) Quantifying the role of angiogenesis in malignant progression of gliomas: in silico modeling integrates imaging and histology. Cancer Res 71(24):7366–7375

    Article  Google Scholar 

  • Wang CH, Rockhill JK, Mrugala M, Peacock DL, Lai A, Jusenius K, Wardlaw JM, Cloughesy T, Spence AM, Rockne R et al (2009) Prognostic significance of growth kinetics in newly diagnosed glioblastomas revealed by combining serial imaging with a novel biomathematical model. Cancer Res 69(23):9133–9140

    Article  Google Scholar 

  • Yamaguchi T, Kanno I, Uemura K, Fumjo Shishido A, Inugami TO, Murakami M, Suzuki K (1986) Reduction in regional cerebral metabolic rate of oxygen during human aging. Stroke 17(6):1220–1228

    Article  Google Scholar 

  • Yang Y, Lin Hou Y, Li JN, Liu L (2013) Neuronal necrosis and spreading death in a drosophila genetic model. Cell Death Dis 4(7):e723

    Article  Google Scholar 

  • Zagzag D, Zhong H, Scalzitti JM, Laughner E, Simons JW, Semenza GL (2000) Expression of hypoxia-inducible factor 1\(\alpha \) in brain tumors. Cancer 88(11):2606–2618

    Article  Google Scholar 

  • Zagzag D, Lukyanov Y, Li Lan M, Ali A, Esencay M, Mendez O, Yee H, Voura EB, Newcomb EW (2006) Hypoxia-inducible factor 1 and vegf upregulate cxcr4 in glioblastoma: implications for angiogenesis and glioma cell invasion. Lab Investig 86(12):1221

    Article  Google Scholar 

Download references

Acknowledgements

The authors gratefully acknowledge funding from the National Cancer Institute (U54CA193489) and the School of Mathematical Sciences at the University of Nottingham.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lee Curtin.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Appendix

Appendix

As discussed in the main body of this work, we wanted to show that our PIHNA simulations were following different eigenvalues depending on the value of \(D_h/D_c\). In the linearized regime ahead of the wave, we expect that \({\hat{c}} = {\bar{c}}\exp (\lambda (x-st))\), such that

$$\begin{aligned} \frac{\partial {(\log (c))}}{\partial {r}} \sim \lambda . \end{aligned}$$
(26)

In Fig. 6, we present simulations at a T2 radius of 30cm. We see for the simulation with \(D_h/D_c = 0.1\), \(\partial {(\log (c))}/\partial {r}\) follows \(\lambda _1\) ahead of the traveling wave, whereas for \(D_h/D_c = 10\), \(\partial {(\log (c))}/\partial {r}\) follows \(\lambda _4\).

Fig. 6
figure 6

The gradient of the \(\log \) of the normoxic cells is plotted for a T2 radius of 30 cm. As described in the main text, the leading edge of this simulated gradient (ignoring boundary effects present close to the edge of the domain) should follow the eigenvalue that controls the dynamics of the PIHNA model. Simulations presented here correspond with those presented in Fig. 3. The simulation with \(D_h/D_c = 0.1\) agrees more closely with \(\lambda _1\), whereas the simulation with \(D_h/D_c = 10\) follows \(\lambda _4\). The results of these support the eigenvalue and eigenvector analysis in the main body of this work

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Curtin, L., Hawkins-Daarud, A., van der Zee, K.G. et al. Speed Switch in Glioblastoma Growth Rate due to Enhanced Hypoxia-Induced Migration. Bull Math Biol 82, 43 (2020). https://doi.org/10.1007/s11538-020-00718-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s11538-020-00718-x

Keywords

Navigation